Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PTPRD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDIA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DESI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927843 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ALS2CR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928435 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060363 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACUL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SENP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on